Norethindrone recalls
The FDA has published 8 recalls involving Norethindrone since 2013. The latest was reported on 24 Jun 2026. Most were for benzene. Teva Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls8since 2013
Last 12 months1reported
Class I113% of total
Ongoing3latest 24 Jun 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 13%Class II 2 25%Class III 5 63%
Why norethindrone is recalled
Companies
Brands
By year
Ongoing norethindrone recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Alyacen 7/7/7, Norethindrone recalled by Glenmark PharmaceuticalsAlyacen 1/35 | Glenmark Pharmaceuticals Inc., USA | Potency & Assay | Nationwide |
| Drug | CLASS III | Nortrel 7/7/7 (norethindrone recalled by Teva Pharmaceuticals USANortrel 7/7/7 | Teva Pharmaceuticals USA | Packaging Defects | Nationwide |
| Drug | CLASS III | Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35 recalledNortrel | Teva Pharmaceuticals USA | Packaging Defects | Nationwide |
All norethindrone recalls, newest first
8 totalShould you stop taking Norethindrone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.